CSF1R and Alzheimer disease: In order to quantify CSF1R densities in human brain sections, in vitro Bmax measurements were conducted with [3H]1 in post-mortem human brain sections from individuals with either an AD diagnosis or age-matched (non-AD) controls in inferior parietal cortex, frontal cortex and hippocampus.